Clinical Trial Update: MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

View source ↗

Summary

This completed clinical trial evaluated the MAFLD fibrosis score's ability to detect fibrotic NASH in Egyptian patients with metabolic-associated fatty liver di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic-associated Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Tanta University | Conditions: Metabolic- Associated Fatty Liver Disease (MAFLD) | Status: COMPLETED